Makarov, Danil V. http://orcid.org/0000-0002-0565-9272
Feuer, Zachary
Ciprut, Shannon
Lopez, Natalia Martinez
Fagerlin, Angela
Shedlin, Michele
Gold, Heather T.
Li, Huilin
Lynch, Gina
Warren, Rueben
Ubel, Peter
Ravenell, Joseph E.
Funding for this research was provided by:
National Institute on Minority Health and Health Disparities (R01MD012243)
Article History
Received: 21 September 2020
Accepted: 20 January 2021
First Online: 10 February 2021
Ethics approval and consent to participate
: This study will be conducted in full conformity with Regulations for the Protection of Human Subjects of Research codified in 45 CFR Part 46. The protocol, informed consent form(s), recruitment materials, and all participant materials have been reviewed and approved by the New York University School of Medicine Institutional Review Board (i18-00514). Any amendment to the protocol will require review and approval by the IRB before the changes are implemented to the study. All changes to the consent form will be IRB approved; a determination will be made regarding whether previously consented participants need to be re-consented.Consent forms describing in detail the study intervention, study procedures, and risks are given to the participant and written documentation of informed consent is required prior to starting intervention. All participants will receive a verbal explanation in terms suited to their comprehension of the purposes, procedures, and potential risks of the study and of their rights as research participants. Participants will have the opportunity to carefully review the written consent form and ask questions prior to signing. The participants should have the opportunity to discuss the study with their surrogates or think about it prior to agreeing to participate. The participant will sign the informed consent document prior to any procedures being done specifically for the study. Subjects will sign written full informed consent and audio consent form prior to enrollment in the study.
: Not applicable.
: The authors have no financial or non-financial competing interests to be declared.